the pharmacy thing finally clicked for me and I want to write it down
the pharmacy thing finally clicked for me and I want to write it down, and I am aware this is a minority view on this board.
Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.
a shortage in one member state is not a shortage in all of them
Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.
Apotheke pricing and pharmacy pricing elsewhere are different systems
Is the prescription from the same country as the pharmacy?
the EMA authorises, member states decide who pays
Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.
keep the prescription and the receipt, both matter for claims
keep the prescription and the receipt, both matter for claims
Adding the practical step — read your own country’s published criteria. They exist and they are definitive.
That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.
Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.